These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16729402)

  • 1. Morphology and location of restenosis following bare metal coronary stenting.
    Schweiger MJ; Ansari E; Giugliano GR; Mathew J; Islam A; Morrison J; Cook JR
    J Invasive Cardiol; 2006 Apr; 18(4):165-8. PubMed ID: 16729402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents.
    Minutello RM; Bhagan S; Feldman D; Sharma A; Hong MK; Wong SC
    Am J Cardiol; 2006 Feb; 97(4):499-501. PubMed ID: 16461045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stent length and lesion length on coronary restenosis.
    Mauri L; O'Malley AJ; Cutlip DE; Ho KK; Popma JJ; Chauhan MS; Baim DS; Cohen DJ; Kuntz RE
    Am J Cardiol; 2004 Jun; 93(11):1340-6, A5. PubMed ID: 15165911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.
    Lemos PA; Hoye A; Goedhart D; Arampatzis CA; Saia F; van der Giessen WJ; McFadden E; Sianos G; Smits PC; Hofma SH; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2004 Mar; 109(11):1366-70. PubMed ID: 14993127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
    Nikolsky E; Kosinski E; Mishkel GJ; Kimmelstiel C; McGarry TF; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW
    Am J Cardiol; 2005 Mar; 95(6):709-15. PubMed ID: 15757595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial.
    Alfonso F; Cequier A; Angel J; Martí V; Zueco J; Bethencourt A; Mantilla R; López-Minguez JR; Gómez-Recio M; Morís C; Perez-Vizcayno MJ; Fernández C; Macaya C; Seabra-Gomes R;
    Am Heart J; 2006 Mar; 151(3):681.e1-681.e9. PubMed ID: 16504631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late in-stent restenosis in a bare metal stent.
    Koutouzis M; Nikolidakis S; Arealis G; Kyriakides ZS
    Cardiology; 2007; 107(4):360-1. PubMed ID: 17283426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
    Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE
    Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation.
    Colombo A; Orlic D; Stankovic G; Corvaja N; Spanos V; Montorfano M; Liistro F; Carlino M; Airoldi F; Chieffo A; Di Mario C
    Circulation; 2003 May; 107(17):2178-80. PubMed ID: 12719283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularization.
    Jonas M; Resnic FS; Levin AD; Arora N; Rogers CD
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):175-83. PubMed ID: 17630659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary bifurcation lesions: to stent one branch or both?
    Assali AR; Teplitsky I; Hasdai D; Rechavia E; Solodky A; Sela O; Butto N; Shor N; Fuchs S; Battler A; Kornowski R
    J Invasive Cardiol; 2004 Sep; 16(9):447-50. PubMed ID: 15353821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compare drug-eluting stent to bare-metal stent in prognosis on treating diffuse coronary lesions].
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):487-91. PubMed ID: 16842660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting.
    Dietz U; Holz N; Dauer C; Lambertz H
    Heart; 2006 Jan; 92(1):80-4. PubMed ID: 15883134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of recurrent restenosis after coronary stenting: an analysis of 197 patients.
    Kishi K; Hiasa Y; Suzuki N; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Invasive Cardiol; 2002 Apr; 14(4):187-91. PubMed ID: 11923572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.
    Waksman R; Ajani AE; Pichard AD; Torguson R; Pinnow E; Canos D; Satler LF; Kent KM; Kuchulakanti P; Pappas C; Gambone L; Weissman N; Abbott MC; Lindsay J;
    J Am Coll Cardiol; 2004 Oct; 44(7):1386-92. PubMed ID: 15464317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
    Thuesen L; Kelbaek H; Kløvgaard L; Helqvist S; Jørgensen E; Aljabbari S; Krusell LR; Jensen GV; Bøtker HE; Saunamäki K; Lassen JF; van Weert A;
    Am Heart J; 2006 Dec; 152(6):1140-5. PubMed ID: 17161067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.